title: Comment on "Neutrophil to lymphocyte ratio improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents".
authors.affiliation: Division of Adult Hematology, Department of Internal Medicine, Gazi University Faculty of Medicine, Göksu Mah., Erzurum Kongre Cad., Göksu Metrokent Sitesi, A-3 Blok, No 26, Eryaman, Ankara, TÜRKİYE. burakuz78@gmail.com.
authors.forename: Burak
authors.initials: B
authors.lastname: Uz
mesh_terms: D015507:Drugs, Investigational / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D060828:Induction Chemotherapy; D008214:Lymphocytes / Q000473:pathology*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology*; D009504:Neutrophils / Q000473:pathology*
chemical_list: D015507:Drugs, Investigational